BioPharm International-04-01-2011

New Binary Gas Integrity Test Improves Membrane Quality Assurance

Research and development headed for divorce.

The authors describe considerations and best practices for meeting drug substance uniformity.

A series of advancements has changed the way bioprocesses are developed and optimized.

Mergers and acquisitions expected to increase, as big companies bolster piplines by acquiring smaller biotech companies.

The authors developed a test for defects in filter membranes.

Industry starts the year with a positive spin.

Courts and Congress seek to reshape policies and programs affecting drug costs and access.

Supply-chain analytics can lead to increased profitability.